Skin graft rejection by beta 2-microglobulin-deficient mice

doi:10.1084/jem.175.4.885

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Zijlstra, M.
	Articles by Jaenisch, R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Zijlstra, M.
	Articles by Jaenisch, R.


Social Bookmarking

	What's this?

ARTICLES

Skin graft rejection by beta 2-microglobulin-deficient mice

M Zijlstra, H Auchincloss Jr, JM Loring, CM Chase, PS Russell and R Jaenisch
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts.

Mice homozygous for a beta 2-microglobulin (beta 2-m) gene disruption lack beta 2-m protein and are deficient for functional major histocompatibility complex class I (MHC-I) molecules. The mutant mice have normal numbers of CD4+8- T helper cells, but lack MHC-I-directed CD4-8+ cytotoxic T lymphocytes (CTLs). In this study we used the beta 2- m mutant mice to study the importance of MHC-I-directed immunity in skin graft rejection. Our results indicate that MHC-I-directed CD8+ CTLs are not essential in the rejection of allografts with whole MHC or multiple minor H differences. However, the absence of MHC-I-guided immunity profoundly reduces the ability of mutant mice to reject H-Y disparate grafts. In addition, we show that natural killer cells which vigorously reject MHC-I-deficient bone marrow grafts, are not effective in the destruction of MHC-I-deficient skin grafts.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Laffont, S., Seillet, C., Ortaldo, J., Coudert, J. D., Guery, J.-C. (2008). Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 112: 661-671 [Abstract] [Full Text]
Nomi, H., Tashiro-Yamaji, J., Yamamoto, Y., Miura-Takeda, S., Miyoshi-Higashino, M., Takahashi, T., Azuma, H., Ueda, H., Katsuoka, Y., Kubota, T., Yoshida, R. (2007). Acute Rejection of Allografted CTL-Susceptible Leukemia Cells from Perforin/Fas Ligand Double-Deficient Mice. J. Immunol. 179: 2180-2186 [Abstract] [Full Text]
Chisholm, S. E., Reyburn, H. T. (2006). Recognition of Vaccinia Virus-Infected Cells by Human Natural Killer Cells Depends on Natural Cytotoxicity Receptors. J. Virol. 80: 2225-2233 [Abstract] [Full Text]
Uehara, S., Chase, C. M., Kitchens, W. H., Rose, H. S., Colvin, R. B., Russell, P. S., Madsen, J. C. (2005). NK Cells Can Trigger Allograft Vasculopathy: The Role of Hybrid Resistance in Solid Organ Allografts. J. Immunol. 175: 3424-3430 [Abstract] [Full Text]
Tanaka, Y., Koido, S., Xia, J., Ohana, M., Liu, C., Cote, G. M., Sawyer, D. B., Calderwood, S., Gong, J. (2004). Development of Antigen-Specific CD8+ CTL in MHC Class I-Deficient Mice through CD4 to CD8 Conversion. J. Immunol. 172: 7848-7858 [Abstract] [Full Text]
Coudert, J. D., Coureau, C., Guery, J.-C. (2002). Preventing NK Cell Activation by Donor Dendritic Cells Enhances Allospecific CD4 T Cell Priming and Promotes Th Type 2 Responses to Transplantation Antigens. J. Immunol. 169: 2979-2987 [Abstract] [Full Text]
Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A., Caligiuri, M. A. (2002). Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 100: 1935-1947 [Abstract] [Full Text]
Schell, T. D., Mylin, L. M., Tevethia, S. S., Joyce, S. (2002). The assembly of functional {beta}2-microglobulin-free MHC class I molecules that interact with peptides and CD8+ T lymphocytes. Int Immunol 14: 775-782 [Abstract] [Full Text]
Surquin, M., Le Moine, A., Flamand, V., Nagy, N., Rombaut, K., Demoor, F.-X., Stordeur, P., Salmon, I., Guery, J.-C., Goldman, M., Abramowicz, D. (2002). Skin Graft Rejection Elicited by {beta}2-Microglobulin as a Minor Transplantation Antigen Involves Multiple Effector Pathways: Role of Fas-Fas Ligand Interactions and Th2-Dependent Graft Eosinophil Infiltrates. J. Immunol. 169: 500-506 [Abstract] [Full Text]
Fox-Marsh, A., Harrison, L. C. (2002). Emerging evidence that molecules expressed by mammalian tissue grafts are recognized by the innate immune system. J. Leukoc. Biol. 71: 401-409 [Abstract] [Full Text]
Yoshida, R., Yoneda, Y., Kuriyama, M., Kubota, T. (1999). IFN-{gamma}- and Cell-to-Cell Contact-Dependent Cytotoxicity of Allograft-Induced Macrophages Against Syngeneic Tumor Cells and Cell Lines: An Application of Allografting to Cancer Treatment. J. Immunol. 163: 148-154 [Abstract] [Full Text]
Sandberg, J. K., Karre, K., Glas, R. (1999). Recognition of the Major Histocompatibility Complex Restriction Element Modulates CD8+ T Cell Specificity and Compensates for Loss of� T Cell Receptor Contacts with the Specific Peptide. J. Exp. Med. 189: 883-894 [Abstract] [Full Text]
Zelenika, D., Adams, E., Mellor, A., Simpson, E., Chandler, P., Stockinger, B., Waldmann, H., Cobbold, S. P. (1998). Rejection of H-Y Disparate Skin Grafts by Monospecific CD4+ Th1 and Th2 Cells: No Requirement for CD8+ T Cells or B Cells. J. Immunol. 161: 1868-1874 [Abstract] [Full Text]
Yoneda, Y., Yoshida, R. (1998). The Role of T Cells in Allografted Tumor Rejection: IFN-{gamma} Released from T Cells Is Essential for Induction of Effector Macrophages in the Rejection Site. J. Immunol. 160: 6012-6017 [Abstract] [Full Text]
Krams, S. M., Hayashi, M., Fox, C. K., Villanueva, J. C., Whitmer, K. J., Burns, W., Esquivel, C. O., Martinez, O. M. (1998). CD8+ Cells Are Not Necessary for Allograft Rejection or the Induction of Apoptosis in an Experimental Model of Small Intestinal Transplantation. J. Immunol. 160: 3673-3680 [Abstract] [Full Text]
Freland, S., Chambers, B. J., Andersson, M., Van Kaer, L., Ljunggren, H.-G. (1998). Rejection of Allogeneic and Syngeneic But Not MHC Class I-Deficient Tumor Grafts by MHC Class I-Deficient Mice. J. Immunol. 160: 572-579 [Abstract] [Full Text]
de la Salle, H, Hanau, D, Fricker, D, Urlacher, A, Kelly, A, Salamero, J, Powis, S., Donato, L, Bausinger, H, Laforet, M, et, al. (1994). Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 265: 237-241 [Abstract]